NIH Funding Announcements Plummet as Political Approval Bottleneck Grows
March 19, 2026 · 2 min read
Jared Klein
The National Institutes of Health has published just 14 Notices of Funding Opportunity in fiscal year 2026 — a staggering 98% projected decline from the 756 NOFOs issued in 2024. The collapse represents the most severe constriction of the federal research funding pipeline in the agency's 87-year history.
The Forecast Graveyard Growing on Grants.gov
The numbers reveal systematic blockage. Of 75 funding announcements forecasted on grants.gov for 2026, only 14 have been approved and published. The remaining 81% sit in what former NIH program officer Elizabeth Ginexi describes as a "forecast graveyard" — fully developed, internally reviewed announcements awaiting political sign-off that never arrives.
The pattern emerged in 2025, when NIH published just 120 of 391 forecasted NOFOs — meaning 271 announcements were written, reviewed, entered into the system, and blocked at the final approval stage. Now the bottleneck has tightened further. Every NOFO must receive clearance from NIH leadership, HHS, and the Office of Management and Budget before it can open for applications — converting what were once scientific decisions into a political gatekeeping process.
Every Major Institute Is Affected
The collapse spans the agency's full portfolio. The National Cancer Institute, historically NIH's most prolific funder, has posted a fraction of its normal output. Programs in infectious disease, mental health, aging, drug abuse, environmental health, and rare diseases are all effectively frozen.
These are not rejected proposals. These are announcements that NIH institutes wrote, vetted internally, and entered into grants.gov — only to be blocked at the final political approval stage. Researchers tracking the forecast system report watching planned opportunities appear, linger for months, and vanish without ever opening for applications.
What Researchers Should Do Right Now
For principal investigators planning NIH submissions, the practical impact is severe. Labs cannot prepare proposals for solicitations that may never materialize. Hiring decisions, equipment purchases, and multi-year research timelines are all suspended in uncertainty.
Grant seekers should monitor the NIH Guide daily for the NOFOs that do get published, as competition for remaining opportunities will be fierce. Diversifying toward NSF, DOE, and private foundation funding — a strategy increasingly tracked at grantedai.com — is no longer optional for labs dependent on NIH support.
In-depth analysis of NIH funding trends and alternative funding strategies is available on the Granted blog.